Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection

Chi Hung Cheng, Chiu Ching Huang, Mei Ling Leu, Chun Yi Fan Chiang, Mai Szu Wu, Ping Chin Lai

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Patients on hemodialysis therapy are at a relatively high risk of exposure to hepatitis B virus (HBV) infection. The prevalence of hepatitis C virus (HCV) infection is even higher and was reported as 33.2% in Taiwan. Although the efficacy of hepatitis B vaccine was well documented, the vaccination schedule in hemodialysis patients is not clearly defined. And under such a high prevalence of HCV infection, little is known about the influence of HCV imposing on HBV vaccination. We studied 50 chronic hemodialysis patients who were serologically negative for the hepatitis B surface antigen (HBsAg), the antibody to the hepatitis B surface antigen (anti-HBs) and the antibody to the hepatitis B core antigen (anti-HBc); 26 of them were positive for the antibody to hepatitis C virus (anti-HCV) test. Recombinant hepatitis B vaccine (Engerix-B) 40 μg per dose was administered by the intramuscular route at deltoid region at 0, 1, 2, 6 and 12 months respectively to all the patients. Forty-six patients had completed the study. The effective seroconversion rate (serum anti-HBs titer > 10 mIU ml -1) at 1 month after the final vaccine was 76.1% (35/46). The effective conversion rates of the anti-HCV (+) group to the anti-HCV(-) were 75% versus 77.3% (P=0.857). Geometric mean anti-HBs titers were 177.67 mIU ml -1 versus 189.28 mIU ml -1 (P = 0.867). Our results showed that five-dose injections of HBV vaccine do not present a superior outcome to the four-dose regimen comparing to published data. The status of positivity of anti-HCV do not pose an suboptimal effect on HBV vaccination of hemodialysis patients.

Original languageEnglish
Pages (from-to)1353-1357
Number of pages5
JournalVaccine
Volume15
Issue number12-13
DOIs
Publication statusPublished - Aug 1997
Externally publishedYes

Keywords

  • Hemodialysis patients
  • Hepatitis B vaccine
  • Hepatitis C infection
  • Immunogenicity

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Fingerprint Dive into the research topics of 'Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection'. Together they form a unique fingerprint.

  • Cite this

    Cheng, C. H., Huang, C. C., Leu, M. L., Chiang, C. Y. F., Wu, M. S., & Lai, P. C. (1997). Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection. Vaccine, 15(12-13), 1353-1357. https://doi.org/10.1016/S0264-410X(97)00037-6